Global Erythropoietin (EPO) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Erythropoietin (EPO) market size was valued at USD 9422.9 million in 2023 and is forecast to a readjusted size of USD 13750 million by 2030 with a CAGR of 5.6% during review period.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

The Global Info Research report includes an overview of the development of the Erythropoietin (EPO) industry chain, the market status of Anemia (Epoetin-alfa, Darbepoetin-alfa), Kidney Disorders (Epoetin-alfa, Darbepoetin-alfa), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Erythropoietin (EPO).

Regionally, the report analyzes the Erythropoietin (EPO) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Erythropoietin (EPO) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Erythropoietin (EPO) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Erythropoietin (EPO) industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Epoetin-alfa, Darbepoetin-alfa).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Erythropoietin (EPO) market.

Regional Analysis: The report involves examining the Erythropoietin (EPO) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Erythropoietin (EPO) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Erythropoietin (EPO):
Company Analysis: Report covers individual Erythropoietin (EPO) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Erythropoietin (EPO) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Anemia, Kidney Disorders).

Technology Analysis: Report covers specific technologies relevant to Erythropoietin (EPO). It assesses the current state, advancements, and potential future developments in Erythropoietin (EPO) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Erythropoietin (EPO) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Erythropoietin (EPO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Epoetin-alfa
    Darbepoetin-alfa
    Epoetin-beta
    Others

Market segment by Application
    Anemia
    Kidney Disorders
    Other

Major players covered
    Amgen
    Johnson & Johnson
    Roche
    Galenica
    Emcure
    Kyowa Hakko Kirin
    3SBio
    Biocon
    LG Life Sciences

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erythropoietin (EPO) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Erythropoietin (EPO), with price, sales, revenue and global market share of Erythropoietin (EPO) from 2019 to 2024.
Chapter 3, the Erythropoietin (EPO) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erythropoietin (EPO) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Erythropoietin (EPO) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Erythropoietin (EPO).
Chapter 14 and 15, to describe Erythropoietin (EPO) sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Erythropoietin (EPO)
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Erythropoietin (EPO) Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Epoetin-alfa
        1.3.3 Darbepoetin-alfa
        1.3.4 Epoetin-beta
        1.3.5 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Erythropoietin (EPO) Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Anemia
        1.4.3 Kidney Disorders
        1.4.4 Other
    1.5 Global Erythropoietin (EPO) Market Size & Forecast
        1.5.1 Global Erythropoietin (EPO) Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Erythropoietin (EPO) Sales Quantity (2019-2030)
        1.5.3 Global Erythropoietin (EPO) Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Erythropoietin (EPO) Product and Services
        2.1.4 Amgen Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Amgen Recent Developments/Updates
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Erythropoietin (EPO) Product and Services
        2.2.4 Johnson & Johnson Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Johnson & Johnson Recent Developments/Updates
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Erythropoietin (EPO) Product and Services
        2.3.4 Roche Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Roche Recent Developments/Updates
    2.4 Galenica
        2.4.1 Galenica Details
        2.4.2 Galenica Major Business
        2.4.3 Galenica Erythropoietin (EPO) Product and Services
        2.4.4 Galenica Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Galenica Recent Developments/Updates
    2.5 Emcure
        2.5.1 Emcure Details
        2.5.2 Emcure Major Business
        2.5.3 Emcure Erythropoietin (EPO) Product and Services
        2.5.4 Emcure Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Emcure Recent Developments/Updates
    2.6 Kyowa Hakko Kirin
        2.6.1 Kyowa Hakko Kirin Details
        2.6.2 Kyowa Hakko Kirin Major Business
        2.6.3 Kyowa Hakko Kirin Erythropoietin (EPO) Product and Services
        2.6.4 Kyowa Hakko Kirin Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Kyowa Hakko Kirin Recent Developments/Updates
    2.7 3SBio
        2.7.1 3SBio Details
        2.7.2 3SBio Major Business
        2.7.3 3SBio Erythropoietin (EPO) Product and Services
        2.7.4 3SBio Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 3SBio Recent Developments/Updates
    2.8 Biocon
        2.8.1 Biocon Details
        2.8.2 Biocon Major Business
        2.8.3 Biocon Erythropoietin (EPO) Product and Services
        2.8.4 Biocon Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Biocon Recent Developments/Updates
    2.9 LG Life Sciences
        2.9.1 LG Life Sciences Details
        2.9.2 LG Life Sciences Major Business
        2.9.3 LG Life Sciences Erythropoietin (EPO) Product and Services
        2.9.4 LG Life Sciences Erythropoietin (EPO) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 LG Life Sciences Recent Developments/Updates

3 Competitive Environment: Erythropoietin (EPO) by Manufacturer
    3.1 Global Erythropoietin (EPO) Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Erythropoietin (EPO) Revenue by Manufacturer (2019-2024)
    3.3 Global Erythropoietin (EPO) Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Erythropoietin (EPO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Erythropoietin (EPO) Manufacturer Market Share in 2023
        3.4.2 Top 6 Erythropoietin (EPO) Manufacturer Market Share in 2023
    3.5 Erythropoietin (EPO) Market: Overall Company Footprint Analysis
        3.5.1 Erythropoietin (EPO) Market: Region Footprint
        3.5.2 Erythropoietin (EPO) Market: Company Product Type Footprint
        3.5.3 Erythropoietin (EPO) Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Erythropoietin (EPO) Market Size by Region
        4.1.1 Global Erythropoietin (EPO) Sales Quantity by Region (2019-2030)
        4.1.2 Global Erythropoietin (EPO) Consumption Value by Region (2019-2030)
        4.1.3 Global Erythropoietin (EPO) Average Price by Region (2019-2030)
    4.2 North America Erythropoietin (EPO) Consumption Value (2019-2030)
    4.3 Europe Erythropoietin (EPO) Consumption Value (2019-2030)
    4.4 Asia-Pacific Erythropoietin (EPO) Consumption Value (2019-2030)
    4.5 South America Erythropoietin (EPO) Consumption Value (2019-2030)
    4.6 Middle East and Africa Erythropoietin (EPO) Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    5.2 Global Erythropoietin (EPO) Consumption Value by Type (2019-2030)
    5.3 Global Erythropoietin (EPO) Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    6.2 Global Erythropoietin (EPO) Consumption Value by Application (2019-2030)
    6.3 Global Erythropoietin (EPO) Average Price by Application (2019-2030)

7 North America
    7.1 North America Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    7.2 North America Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    7.3 North America Erythropoietin (EPO) Market Size by Country
        7.3.1 North America Erythropoietin (EPO) Sales Quantity by Country (2019-2030)
        7.3.2 North America Erythropoietin (EPO) Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    8.2 Europe Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    8.3 Europe Erythropoietin (EPO) Market Size by Country
        8.3.1 Europe Erythropoietin (EPO) Sales Quantity by Country (2019-2030)
        8.3.2 Europe Erythropoietin (EPO) Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Erythropoietin (EPO) Market Size by Region
        9.3.1 Asia-Pacific Erythropoietin (EPO) Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Erythropoietin (EPO) Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    10.2 South America Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    10.3 South America Erythropoietin (EPO) Market Size by Country
        10.3.1 South America Erythropoietin (EPO) Sales Quantity by Country (2019-2030)
        10.3.2 South America Erythropoietin (EPO) Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Erythropoietin (EPO) Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Erythropoietin (EPO) Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Erythropoietin (EPO) Market Size by Country
        11.3.1 Middle East & Africa Erythropoietin (EPO) Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Erythropoietin (EPO) Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Erythropoietin (EPO) Market Drivers
    12.2 Erythropoietin (EPO) Market Restraints
    12.3 Erythropoietin (EPO) Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Erythropoietin (EPO) and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Erythropoietin (EPO)
    13.3 Erythropoietin (EPO) Production Process
    13.4 Erythropoietin (EPO) Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Erythropoietin (EPO) Typical Distributors
    14.3 Erythropoietin (EPO) Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Erythropoietin (EPO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Erythropoietin (EPO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Amgen Basic Information, Manufacturing Base and Competitors
    Table 4. Amgen Major Business
    Table 5. Amgen Erythropoietin (EPO) Product and Services
    Table 6. Amgen Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Amgen Recent Developments/Updates
    Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 9. Johnson & Johnson Major Business
    Table 10. Johnson & Johnson Erythropoietin (EPO) Product and Services
    Table 11. Johnson & Johnson Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Johnson & Johnson Recent Developments/Updates
    Table 13. Roche Basic Information, Manufacturing Base and Competitors
    Table 14. Roche Major Business
    Table 15. Roche Erythropoietin (EPO) Product and Services
    Table 16. Roche Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Roche Recent Developments/Updates
    Table 18. Galenica Basic Information, Manufacturing Base and Competitors
    Table 19. Galenica Major Business
    Table 20. Galenica Erythropoietin (EPO) Product and Services
    Table 21. Galenica Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Galenica Recent Developments/Updates
    Table 23. Emcure Basic Information, Manufacturing Base and Competitors
    Table 24. Emcure Major Business
    Table 25. Emcure Erythropoietin (EPO) Product and Services
    Table 26. Emcure Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Emcure Recent Developments/Updates
    Table 28. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
    Table 29. Kyowa Hakko Kirin Major Business
    Table 30. Kyowa Hakko Kirin Erythropoietin (EPO) Product and Services
    Table 31. Kyowa Hakko Kirin Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Kyowa Hakko Kirin Recent Developments/Updates
    Table 33. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 34. 3SBio Major Business
    Table 35. 3SBio Erythropoietin (EPO) Product and Services
    Table 36. 3SBio Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. 3SBio Recent Developments/Updates
    Table 38. Biocon Basic Information, Manufacturing Base and Competitors
    Table 39. Biocon Major Business
    Table 40. Biocon Erythropoietin (EPO) Product and Services
    Table 41. Biocon Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Biocon Recent Developments/Updates
    Table 43. LG Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 44. LG Life Sciences Major Business
    Table 45. LG Life Sciences Erythropoietin (EPO) Product and Services
    Table 46. LG Life Sciences Erythropoietin (EPO) Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. LG Life Sciences Recent Developments/Updates
    Table 48. Global Erythropoietin (EPO) Sales Quantity by Manufacturer (2019-2024) & (Units)
    Table 49. Global Erythropoietin (EPO) Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 50. Global Erythropoietin (EPO) Average Price by Manufacturer (2019-2024) & (USD/Unit)
    Table 51. Market Position of Manufacturers in Erythropoietin (EPO), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 52. Head Office and Erythropoietin (EPO) Production Site of Key Manufacturer
    Table 53. Erythropoietin (EPO) Market: Company Product Type Footprint
    Table 54. Erythropoietin (EPO) Market: Company Product Application Footprint
    Table 55. Erythropoietin (EPO) New Market Entrants and Barriers to Market Entry
    Table 56. Erythropoietin (EPO) Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Erythropoietin (EPO) Sales Quantity by Region (2019-2024) & (Units)
    Table 58. Global Erythropoietin (EPO) Sales Quantity by Region (2025-2030) & (Units)
    Table 59. Global Erythropoietin (EPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 60. Global Erythropoietin (EPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 61. Global Erythropoietin (EPO) Average Price by Region (2019-2024) & (USD/Unit)
    Table 62. Global Erythropoietin (EPO) Average Price by Region (2025-2030) & (USD/Unit)
    Table 63. Global Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 64. Global Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 65. Global Erythropoietin (EPO) Consumption Value by Type (2019-2024) & (USD Million)
    Table 66. Global Erythropoietin (EPO) Consumption Value by Type (2025-2030) & (USD Million)
    Table 67. Global Erythropoietin (EPO) Average Price by Type (2019-2024) & (USD/Unit)
    Table 68. Global Erythropoietin (EPO) Average Price by Type (2025-2030) & (USD/Unit)
    Table 69. Global Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 70. Global Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 71. Global Erythropoietin (EPO) Consumption Value by Application (2019-2024) & (USD Million)
    Table 72. Global Erythropoietin (EPO) Consumption Value by Application (2025-2030) & (USD Million)
    Table 73. Global Erythropoietin (EPO) Average Price by Application (2019-2024) & (USD/Unit)
    Table 74. Global Erythropoietin (EPO) Average Price by Application (2025-2030) & (USD/Unit)
    Table 75. North America Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 76. North America Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 77. North America Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 78. North America Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 79. North America Erythropoietin (EPO) Sales Quantity by Country (2019-2024) & (Units)
    Table 80. North America Erythropoietin (EPO) Sales Quantity by Country (2025-2030) & (Units)
    Table 81. North America Erythropoietin (EPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 82. North America Erythropoietin (EPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 83. Europe Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 84. Europe Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 85. Europe Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 86. Europe Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 87. Europe Erythropoietin (EPO) Sales Quantity by Country (2019-2024) & (Units)
    Table 88. Europe Erythropoietin (EPO) Sales Quantity by Country (2025-2030) & (Units)
    Table 89. Europe Erythropoietin (EPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 90. Europe Erythropoietin (EPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 91. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 92. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 93. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 94. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 95. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Region (2019-2024) & (Units)
    Table 96. Asia-Pacific Erythropoietin (EPO) Sales Quantity by Region (2025-2030) & (Units)
    Table 97. Asia-Pacific Erythropoietin (EPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 98. Asia-Pacific Erythropoietin (EPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 99. South America Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 100. South America Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 101. South America Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 102. South America Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 103. South America Erythropoietin (EPO) Sales Quantity by Country (2019-2024) & (Units)
    Table 104. South America Erythropoietin (EPO) Sales Quantity by Country (2025-2030) & (Units)
    Table 105. South America Erythropoietin (EPO) Consumption Value by Country (2019-2024) & (USD Million)
    Table 106. South America Erythropoietin (EPO) Consumption Value by Country (2025-2030) & (USD Million)
    Table 107. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Type (2019-2024) & (Units)
    Table 108. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Type (2025-2030) & (Units)
    Table 109. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Application (2019-2024) & (Units)
    Table 110. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Application (2025-2030) & (Units)
    Table 111. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Region (2019-2024) & (Units)
    Table 112. Middle East & Africa Erythropoietin (EPO) Sales Quantity by Region (2025-2030) & (Units)
    Table 113. Middle East & Africa Erythropoietin (EPO) Consumption Value by Region (2019-2024) & (USD Million)
    Table 114. Middle East & Africa Erythropoietin (EPO) Consumption Value by Region (2025-2030) & (USD Million)
    Table 115. Erythropoietin (EPO) Raw Material
    Table 116. Key Manufacturers of Erythropoietin (EPO) Raw Materials
    Table 117. Erythropoietin (EPO) Typical Distributors
    Table 118. Erythropoietin (EPO) Typical Customers
List of Figures
    Figure 1. Erythropoietin (EPO) Picture
    Figure 2. Global Erythropoietin (EPO) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Erythropoietin (EPO) Consumption Value Market Share by Type in 2023
    Figure 4. Epoetin-alfa Examples
    Figure 5. Darbepoetin-alfa Examples
    Figure 6. Epoetin-beta Examples
    Figure 7. Others Examples
    Figure 8. Global Erythropoietin (EPO) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 9. Global Erythropoietin (EPO) Consumption Value Market Share by Application in 2023
    Figure 10. Anemia Examples
    Figure 11. Kidney Disorders Examples
    Figure 12. Other Examples
    Figure 13. Global Erythropoietin (EPO) Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Erythropoietin (EPO) Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Erythropoietin (EPO) Sales Quantity (2019-2030) & (Units)
    Figure 16. Global Erythropoietin (EPO) Average Price (2019-2030) & (USD/Unit)
    Figure 17. Global Erythropoietin (EPO) Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Erythropoietin (EPO) Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Erythropoietin (EPO) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Erythropoietin (EPO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Erythropoietin (EPO) Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Erythropoietin (EPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Erythropoietin (EPO) Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Erythropoietin (EPO) Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Erythropoietin (EPO) Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Erythropoietin (EPO) Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Erythropoietin (EPO) Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Erythropoietin (EPO) Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Erythropoietin (EPO) Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Erythropoietin (EPO) Average Price by Type (2019-2030) & (USD/Unit)
    Figure 32. Global Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Erythropoietin (EPO) Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Erythropoietin (EPO) Average Price by Application (2019-2030) & (USD/Unit)
    Figure 35. North America Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Erythropoietin (EPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Erythropoietin (EPO) Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Erythropoietin (EPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Erythropoietin (EPO) Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Erythropoietin (EPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Erythropoietin (EPO) Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Erythropoietin (EPO) Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Erythropoietin (EPO) Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Erythropoietin (EPO) Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Erythropoietin (EPO) Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Erythropoietin (EPO) Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Erythropoietin (EPO) Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Erythropoietin (EPO) Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Erythropoietin (EPO) Market Drivers
    Figure 76. Erythropoietin (EPO) Market Restraints
    Figure 77. Erythropoietin (EPO) Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Erythropoietin (EPO) in 2023
    Figure 80. Manufacturing Process Analysis of Erythropoietin (EPO)
    Figure 81. Erythropoietin (EPO) Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences